SCHEMBL3156385

SCHEMBL3156385

CC(=O)NCCNc1cc(N2CCN(C(=O)c3ccc(C(C)(C)C)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 3/20 0.50
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 3/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
GAA P10253 2/20 0.44
APAF1 O14727 1/20 0.44
KDM6B O15054 2/20 0.43
NR1I2 O75469 1/20 0.43
CHRNA1 P02708 1/20 0.43
MAOB P27338 1/20 0.43
OPRM1 P35372 1/20 0.43
AHR P35869 1/20 0.43
AVPR1A P37288 1/20 0.43
OPRK1 P41145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3176024 0.92 SLC6A7 (0.47) GBA1MEN1KMT2ALMNAALDH1A1
SCHEMBL3171321 0.92 GBA1 (0.54) GBA1MEN1KMT2ALMNAALDH1A1
SCHEMBL3155347 0.92 GBA1 (0.49) GBA1LMNAALDH1A1DRD2DRD3
SCHEMBL3156246 0.91 GBA1 (0.49) GBA1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL3166309 0.91 GBA1 (0.48) GBA1LMNAALDH1A1MAPTHTT
SCHEMBL3163851 0.90 GBA1 (0.48) GBA1LMNAALDH1A1DRD2DRD3
SCHEMBL3172414 0.90 GBA1 (0.50) GBA1MEN1KMT2ALMNAALDH1A1
SCHEMBL3163116 0.89 KDM6B (0.50) GBA1SMN1; SMN2LMNAALDH1A1KDM6B
SCHEMBL3162073 0.89 GBA1 (0.45) GBA1LMNAALDH1A1DRD2DRD3
SCHEMBL3175804 0.89 GBA1 (0.51) GBA1MEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed